Ani Pharmaceuticals (ANIP) EBITDA (2011 - 2026)
Ani Pharmaceuticals (ANIP) posted EBITDA of $38.9 million for Q1 2026, up 11.85% sequentially from $34.8 million in Q4 2025, and up 48.46% YoY from $26.2 million in Q1 2025.
Ani Pharmaceuticals (ANIP) EBITDA (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported EBITDA for 16 years, with the latest figure at $38.9 million in Q1 2026.
- Quarterly EBITDA rose 48.46% year-over-year to $38.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123.8 million (up 1814.43% YoY) and the FY2025 annual result came in at $111.1 million, up 18922.77% from the prior year.
- EBITDA climbed to $38.9 million in Q1 2026 per ANIP's latest filing, from $34.8 million in the prior quarter.
- Over five years, EBITDA peaked at $38.9 million in Q1 2026 and troughed at -$20.5 million in Q3 2024.
- A 5-year average of $9.5 million and a median of $9.9 million in 2023 frame the typical range for EBITDA.
- The sharpest annual moves came in 2022 and 2025: EBITDA tumbled 730.38% in 2022, then soared 894.13% in 2025.
- Over 5 years, EBITDA stood at $1.8 million in 2022, then jumped by 269.56% to $6.7 million in 2023, then plunged by 165.09% to -$4.4 million in 2024, then jumped by 894.13% to $34.8 million in 2025, then grew by 11.85% to $38.9 million in 2026.
- According to Business Quant data, EBITDA over the past three periods registered $38.9 million, $34.8 million, and $36.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 40.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.46 Mn |
| Mar 31, 2026 | 38.89 Mn |
| Dec 31, 2025 | 34.77 Mn |
| Sep 30, 2025 | 36.24 Mn |
| Jun 30, 2025 | 13.89 Mn |
| Mar 31, 2025 | 26.19 Mn |
| Dec 31, 2024 | -4.38 Mn |
| Sep 30, 2024 | -20.52 Mn |
| Jun 30, 2024 | 5.17 Mn |
| Mar 31, 2024 | 20.31 Mn |
| Dec 31, 2023 | 6.73 Mn |
| Sep 30, 2023 | 17.95 Mn |
| Jun 30, 2023 | 12.40 Mn |
| Mar 31, 2023 | 9.90 Mn |
| Dec 31, 2022 | 1.82 Mn |
| Sep 30, 2022 | -5.00 Mn |
| Jun 30, 2022 | -12.91 Mn |
| Mar 31, 2022 | -19.20 Mn |
| Dec 31, 2021 | -23.72 Mn |
| Sep 30, 2021 | -3.56 Mn |